Overview
Xiaoqun Yang practices in Shanghai, China. Yang is rated as an Experienced expert by MediFind in the treatment of Hemangioblastoma. Their top areas of expertise are Renal Cell Carcinoma (RCC), Inflammatory Myofibroblastic Tumor, Chromophobe Renal Cell Carcinoma, Hemangioma, and Nephrectomy.
Their clinical research consists of co-authoring 69 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Hemangioblastoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chromophobe Renal Cell Carcinoma
- Inflammatory Myofibroblastic Tumor
- Renal Cell Carcinoma (RCC)
- Experienced
- Acrofacial Dysostosis Rodriguez Type
- Acrofrontofacionasal Dysostosis Syndrome
- Adrenal CancerYang isExperienced. Learn about Adrenal Cancer.
- B-Cell LymphomaYang isExperienced. Learn about B-Cell Lymphoma.
- Bone TumorYang isExperienced. Learn about Bone Tumor.
- CalcinosisYang isExperienced. Learn about Calcinosis.